Vitrolife AB ADR VTRLY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $9.50
- Day Range
- $9.50–9.50
- 52-Week Range
- $9.50–18.55
- Bid/Ask
- $0.01 / $1,611.60
- Shares Outstanding
- 135.45M
- Market Cap
- $1.29B
- Volume/Avg
- 5,649 / 1,373
Key Statistics
- Price/Earnings (Normalized)
- 23.05
- Price/Sales
- 3.55
- Dividend Yield (Trailing)
- 1.24%
- Dividend Yield (Forward)
- 1.24%
- Dividend Payment Schedule
- May
- Total Yield
- 1.24%
Company Profile
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,103
- Website
- https://www.vitrolife.com
Valuation
|
Metric
|
VTRLY
|
|---|---|
Price/Earnings (Normalized) | 23.05 |
Price/Book Value | 1.54 |
Price/Sales | 3.55 |
Price/Cash Flow | 15.08 |
Price/Earnings
VTRLY
Financial Strength
|
Metric
|
VTRLY
|
|---|---|
Quick Ratio | 2.91 |
Current Ratio | 3.64 |
Interest Coverage | −64.54 |
Quick Ratio
VTRLY
Profitability
|
Metric
|
VTRLY
|
|---|---|
Return on Assets (Normalized) | −5.41% |
Return on Equity (Normalized) | −7.19% |
Return on Invested Capital (Normalized) | −5.63% |
Return on Assets
VTRLY
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|dTWZpQB | LOCK|llq< | $169B | |||
| Medtronic PLC
MDT
| LOCK|<Y@tN> | LOCK|RLJ@ | $110B | |||
| Stryker Corp
SYK
| LOCK|jtH><!^ | LOCK|V!> | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|&PsFZvD | LOCK|^F># | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|t?!#wg? | LOCK|&^h& | $49B | |||
| DexCom Inc
DXCM
| LOCK|x?JcZ$#? | LOCK|#M@^ | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|>L&g>z% | LOCK|v%h | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|?Y | LOCK|<s@ | $23B | |||
| Steris PLC
STE
| LOCK|>P#w@> | LOCK|l<qM | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|LCj@fyJ% | LOCK|@< | $17B |
United States